Bicycle rides to $200M payday, while lung disease biotech raises $80M
Bicycle Therapeutics raised about $200 million through a public offering at $21.25 per share a few days before its new CFO is slated to step …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
